Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Committee for Orphan Medicinal Products: October 2005 meeting 25 Οκτώβριος 2005Press releaseHumanRare diseases EMEA Public Statement on review of recombinant Factor VIII (FVIII) products (Advate, Kogenate Bayer/Helixate NexGen, Kogenate/Helixate, Recombinate, ReFacto) and inhibitor development 18 Οκτώβριος 2005News European Medicines Agency update on non-selective NSAIDs 17 Οκτώβριος 2005Press releaseMedicines European Medicines Agency: Committee for Medicinal Products for Human Use 10-13 October 2005 13 Οκτώβριος 2005Press releaseHumanMedicines European Medicines Agency welcomes new members and observers to its Management Board 30 Σεπτέμβριος 2005Press releaseCorporate Thomas Lönngren reappointed as Executive Director of the European Medicines Agency 28 Σεπτέμβριος 2005Press releaseMedicines European Medicines Agency statement on Herceptin 22 Σεπτέμβριος 2005Press releaseHumanMedicines European Medicines Agency proposes new, faster scientific advice procedure 22 Σεπτέμβριος 2005Press releaseMedicines European Medicines Agency recommends suspension of Hexavac 20 Σεπτέμβριος 2005Press releaseHumanMedicines European Medicines Agency: Committee for Medicinal Products for Human Use 12-15 September 2005 15 Σεπτέμβριος 2005Press releaseHumanMedicines 1 … 336 337 338 339 340 Page 340 of 384 341 342 343 344 … 384
Committee for Orphan Medicinal Products: October 2005 meeting 25 Οκτώβριος 2005Press releaseHumanRare diseases
EMEA Public Statement on review of recombinant Factor VIII (FVIII) products (Advate, Kogenate Bayer/Helixate NexGen, Kogenate/Helixate, Recombinate, ReFacto) and inhibitor development 18 Οκτώβριος 2005News
European Medicines Agency: Committee for Medicinal Products for Human Use 10-13 October 2005 13 Οκτώβριος 2005Press releaseHumanMedicines
European Medicines Agency welcomes new members and observers to its Management Board 30 Σεπτέμβριος 2005Press releaseCorporate
Thomas Lönngren reappointed as Executive Director of the European Medicines Agency 28 Σεπτέμβριος 2005Press releaseMedicines
European Medicines Agency proposes new, faster scientific advice procedure 22 Σεπτέμβριος 2005Press releaseMedicines
European Medicines Agency recommends suspension of Hexavac 20 Σεπτέμβριος 2005Press releaseHumanMedicines
European Medicines Agency: Committee for Medicinal Products for Human Use 12-15 September 2005 15 Σεπτέμβριος 2005Press releaseHumanMedicines